To include your compound in the COVID-19 Resource Center, submit it here.

FDA approves Keryx's Auryxia for non-dialysis-dependent CKD

Keryx Biopharmaceuticals Inc. (NASDAQ:KERX) said FDA approved an sNDA for

Read the full 103 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE